A randomized, double-blind, placebo-controlled study of the safety and tolerance of regadenoson in subjects with stage 3 or 4 chronic kidney disease.

A randomized, double-blind, placebo-controlled study of the safety and tolerance of regadenoson in subjects with stage 3 or 4 chronic kidney disease.

Item
http://www.wikidata.org/entity/Q35904476
Regadenoson use in patients with chronic obstructive pulmonary disease: the state of current knowledgeNuclear cardiology: 2014 innovations and developmentsEffect of caffeine on SPECT myocardial perfusion imaging during regadenoson pharmacologic stress: a prospective, randomized, multicenter study.Bladder cancer and urothelial impairment: the role of TRPV1 as potential drug target.Safety and tolerability of regadenoson CMR.Prevalence and significance of electrocardiographic changes and side effect profile of regadenoson compared with adenosine during myocardial perfusion imaging.Regadenoson: a focused update.Serious and potentially life threatening complications of cardiac stress testing: Physiological mechanisms and management strategies.Stress SPECT Myocardial Perfusion Imaging in End-Stage Renal Disease.Regadenoson use in chronic kidney disease and end-stage renal disease: A focused review.Prognostic value of regadenoson myocardial single-photon emission computed tomography in patients with different degrees of renal dysfunction.Use of regadenoson in end-stage renal disease.Regadenoson provides perfusion results comparable to adenosine in heterogeneous patient populations: a quantitative analysis from the ADVANCE MPI trials.Regadenoson for myocardial perfusion imaging: Is it safe?The safety and tolerability of regadenoson in patients with end-stage renal disease: the first prospective evaluation.Regadenoson pharmacologic rubidium-82 PET: a comparison of quantitative perfusion and function to dipyridamole.
P2860

A randomized, double-blind, placebo-controlled study of the safety and tolerance of regadenoson in subjects with stage 3 or 4 chronic kidney disease.

Item
http://www.wikidata.org/entity/Q35904476
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
A randomized, double-blind, pl ...... 3 or 4 chronic kidney disease.
@ast
A randomized, double-blind, pl ...... 3 or 4 chronic kidney disease.
@en
type
label
A randomized, double-blind, pl ...... 3 or 4 chronic kidney disease.
@ast
A randomized, double-blind, pl ...... 3 or 4 chronic kidney disease.
@en
prefLabel
A randomized, double-blind, pl ...... 3 or 4 chronic kidney disease.
@ast
A randomized, double-blind, pl ...... 3 or 4 chronic kidney disease.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
A randomized, double-blind, pl ...... 3 or 4 chronic kidney disease.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932